Replies to post #1094 on Alaunos Therapeutics Inc (TCRT)

[jondoeuk]

So 2-4 years to complete enrolment and estimated primary completion date is 2028. Based on that I wouldn't expect to see data anytime 'soon.' Also, SB is being used [1] and we know from other data acquired resistance is going to be a problem [2]. In addition, nothing has been discussed about ways to try and improve the depth and duration in patients that do respond.

Refs:
1 https://postimg.cc/hQg9nqXX
2 https://cancerimmunolres.aacrjournals.org/content/7/4/534.long